Enoxaparin for the long-term therapy of venous thromboembolism in patients with cancer and renal insufficiency

CONCLUSIONS: Among cancer patients with severe RI, fatal PE was 5-fold more common than fatal bleeding. The recommended doses of enoxaparin in these patients should be revisited.PMID:37832588 | DOI:10.1055/a-2191-7510

Source: Thrombosis and Haemostasis - October 13, 2023 Category: Hematology Authors: Patricia Sig üenza Juan Jos é López Núñez Concepci ón Falga Tirado Covadonga G ómez-Cuervo Antoni Riera-Mestre A ída Gil-Díaz Peter Verhamme Ana Cristina Montenegro Cristina Barbagelata-L ópez Egidio Imbalzano Manuel Monreal Source Type: research